Tata Trusts to start project to eradicate malaria in India
The Economic Times, Megha Mandavia, Baiju Kalesh, September 27, 2017 MUMBAI: Tata Trusts, the philanthropic arm of the Tata Group, is starting on a project to eradicate malaria from India completely by exploring the new gene-editing technology that modifies the DNA of Indian mosquitoes thereby halting the spread of the deadly disease. Tata Trusts will invest $70 million (Rs 458 crore) over the next 5 years by setting up The Tata Institute of Genetics and Society in Bengaluru in collaboration with the University of California San Diego in the US and the Institute for Stem Cell Biology and Regenerative Medicine (InStem) in Bengaluru. Tata Trusts chairman Ratan Tata, managing trustee R Venkataramanan and head of innovation Manoj Kumar will bet the trustees of the new Institute. The centre in the US is already operational and the Indian centre will be launched by end of this year or early next year. "In India, mosquito borne diseases are increas...